Bachanova et al. relied on administering IL-2 diphteria toxin fusion protein (IL2DT) after adoptive transfer of haploidentical NK cells co-administered with IL-2 for patients with refractory AML [5]. The gene discussed is IL2; the disease is acute myeloid leukemia.